Marker Therapeutics Inc (MRKR) — Cash Flow Reinvestment Rate

Latest as of September 2024: 0.00x

Marker Therapeutics Inc (MRKR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $1.00 (capex $1.00 ) from operating cash flow of $1.20 Million. Check Marker Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$1.00
Capex + Investments

Operating Cash Flow

$1.20 Million
USD

Capital Expenditures

$1.00
USD

Marker Therapeutics Inc Cash Flow Reinvestment Rate (2001–2001)

Historical reinvestment intensity for Marker Therapeutics Inc across 1 annual periods. Explore MRKR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Marker Therapeutics Inc (2001–2001)

Year-by-year capital reinvestment analysis for Marker Therapeutics Inc. For live market cap and broader valuation context, see how much is Marker Therapeutics Inc worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2001 0.00x $0.00 $2.38K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow